Skip to content
Tuesday, June 17, 2025
Latest:
  • What is inflammation? Q&A with Dr. Mike Ren
  • A new treatment can potentially change the outlook for patients with Alagille syndrome
  • Mental health for first-time parents
  • Heart attack survivor credits Baylor doctor for a second chance at life
  • It’s a first: implementing safe and effective RSV prevention treatments significantly reduces hospitalizations in infants
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu
Policywise

Finding compassion and resilience in grief

September 27, 2019 Center for Medical Ethics and Health Policy,  Child Death,  Grief,  Jill Oliver Robinson,  Mourning

The year after my daughter Abby died, a collaborator asked how I was doing. Wanting to play it cool, I said, “I’m okay, thanks. Life

Read More
Policywise

Do no harm: A moral imperative to be the change in healthcare

September 20, 2019 Center for Medical Ethics and Health Policy,  health policy,  Healthcare,  Listening,  Resident

“Can you please come see Mr. S in room six? His nose is bleeding, and he is very angry,” the nurse calls. Calls like this

Read More
Policywise

The high costs of diabetes medications

September 13, 2019 Center for Medical Ethics and Health Policy,  Costs,  Diabetes,  Diabetics,  health policy

You can do a lot of things with $1,700 – buy a high-end MacBook with all of the bells and whistles, go on a shopping

Read More
pills
Policywise

Uncharted waters: Navigating requests for experimental medicines

September 6, 2019 Access,  Center for Medical Ethics and Health Policy,  Dr. Christopher Scott,  Expanded Access Program,  Hannah Bablak,  investigational drugs,  Oncologists,  Right-to-Try Act

In May 2018, the federal Right-to-Try Act was signed into law, claiming a new and improved option for patients with no therapeutic options to obtain

Read More
Policywise

The potential impact of contraceptive apps

August 30, 2019 Apps,  Center for Medical Ethics and Health Policy,  Contraception,  Technology

Earlier this summer, new changes were implemented to the Title X family planning program, the federal program dedicated to providing a wide range of reproductive

Read More
Policywise

‘Please respond:’ Crafting an effective research survey

August 23, 2019 Center for Medical Ethics and Health Policy,  Laura Torgerson,  Survey

What compels a busy health professional to participate in a research survey? Health professionals have a poor track record of participating in survey research related

Read More
Policywise

The hardship of being homeless: Why help is needed

August 9, 2019 Center for Medical Ethics and Health Policy,  Dr. Fabrizia Faustinella,  Homeless,  Incarceration,  Mental Illness

More than 550,000 people, including about 36,000 unaccompanied youth under the age of 25, are homeless in the United States on any given night and

Read More
Policywise

Embryo swap scandal reinforces role of genetic counselors

August 2, 2019 Center for Medical Ethics and Health Policy,  Fertility,  Genetic counselors,  Sarah Huguenard

In what should have been the best moment of her life, a New York woman looked down at her newborn twins for the first time

Read More
Policywise

Evaluating new efforts to revamp kidney care

July 26, 2019 Center for Medical Ethics and Health Policy,  Dialysis,  Dr. Kevin Furman Erickson,  kidney disease,  Transplant

Chronic kidney disease affects more than 30 million adults in the United States. Each year, 100,000 patients transition to the most advanced stage of kidney

Read More
Policywise

Is biohacking ‘the practice of medicine?’: Regulators might think so

July 19, 2019 BIohacking,  Center for Medical Ethics and Health Policy,  Citizen Science,  Rebecca Hsu,  Regulation

In an unprecedented regulatory move, a famous biohacker is under investigation in California for allegedly practicing medicine without a license. The complaint against Josiah Zayner,

Read More
  • ← Previous
  • Next →

From the Labs: Image of the Month

Blood vessels (magenta) intertwined with metastatic medulloblastoma tumor cells (green) nestled within the protective layers that surround the mouse spinal cord. From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951